Clofazimine enteropathy in a pediatric bone marrow transplant recipient

Authors
Parizhskaya, M Yousef, NN Di Lorenzo, C Goyal, RK
Citation
M. Parizhskaya et al., Clofazimine enteropathy in a pediatric bone marrow transplant recipient, J PEDIAT, 138(4), 2001, pp. 574-576
Citations number
11
Categorie Soggetti
Pediatrics,"Medical Research General Topics
Journal title
JOURNAL OF PEDIATRICS
ISSN journal
00223476 → ACNP
Volume
138
Issue
4
Year of publication
2001
Pages
574 - 576
Database
ISI
SICI code
0022-3476(200104)138:4<574:CEIAPB>2.0.ZU;2-I
Abstract
Clofazimine, previously used in the treatment of leprosy, is now used for t reatment of Mycobacterium avium complex infection in patients with acquired immune deficiency syndrome, dermatologic disorders, and graft-versus-host disease. An 11-year-old boy developed a severe enteropathy 2 years after in itiation of clofazimine treatment for graft-versus-host disease. Clofazimin e enteropathy caused by crystal deposition can be life-threatening.